Trends of fluoroquinolone-resistant Escherichia coli amongst urinary isolates in children: A 10 year surveillance study

Journal of Medical Microbiology

Volumn 64, Issue 7, 2015, Pages 778-781

  Rose, Lucia ^a   Coulter, Marissa M ^b   Chan, Shannon ^c   Hossain, Jobayer ^d,e   Di Pentima, M Cecilia ^f  

^a Division of Female Pelvic Medicine and Reconstructive Surgery   (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^c NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^d NEMOURS CHILDREN S CLINIC   (United States)

^e UNIVERSITY OF DELAWARE   (United States)

^f VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CHILD; COMMUNITY ACQUIRED INFECTION; DRUG MONITORING; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEMALE; HIGH RISK PATIENT; HOSPITAL INFECTION; HOSPITALIZED CHILD; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; TREND STUDY; URINARY TRACT INFECTION; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG EFFECTS; EPIDEMIOLOGICAL MONITORING; ESCHERICHIA COLI INFECTIONS; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; URINARY TRACT INFECTIONS; URINE;

ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CIPROFLOXACIN; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGICAL MONITORING; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FLUOROQUINOLONES; HUMANS; INFANT; INFANT, NEWBORN; LEVOFLOXACIN; MALE; MICROBIAL SENSITIVITY TESTS; URINARY TRACT INFECTIONS;

EID: 84938300734     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.000072     Document Type: Article

References (8)

1. Boyd, L. B, Atmar, R. L, Randall, G. L, Hamill, R. J, Steffen, D. and Zechiedrich, L. (2008). Increased fluoroquinolone resistance with time in Escherichia coli from > 17,000 patients at a large county hospital as a function of culture site, age, sex, and location. BMC Infect Dis 8, 4.
2. Bradley, J. S, Jackson, M. A. Committee on Infectious Diseases and American Academy of Pediatrics (2011). The use of systemic and topical fluoroquinolones. Pediatrics 128, e1034-e1045.
3. CLSI (2006). Analysis and presentation of cumulative antimicrobial susceptibility test data, Approved Guideline, 2nd edn, M39-A2. Wayne, PA: Clinical and Laboratory Standards Institute.
4. Edlin, R. S, Shapiro, D. J, Hersh, A. L. and Copp, H. L. (2013). Antibiotic resistance patterns of outpatient pediatric urinary tract infections. J Urol 190, 222-227.
5. Fleming, V. H, White, B. P. and Southwood, R. (2014). Resistance of Escherichia coli urinary isolates in ED-treated patients from a community hospital. Am J Emerg Med 32, 864-870.
6. Kim, J. Y, Lautenbach, E, Chu, J, Goyal, M, Nachamkin, I, McGowan, K, Coffin, S. and Zaoutis, T. (2008). Fluoroquinolone resistance in pediatric bloodstream infections because of Escherichia coli and Klebsiella species. Am J Infect Control 36, 70-73.
7. Linder, J. A, Huang, E. S, Steinman, M. A, Gonzales, R. and Stafford, R. S. (2005). Fluoroquinolone prescribing in the United States: 1995 to 2002. Am J Med 118, 259-268.
8. Rose, L, Coulter, M. M, Chan, S, Hossain, J. and Di Pentima, M. C. (2014). The quest for the best metric of antibiotic use and its correlation with the emergence of fluoroquinolone resistance in children. Pediatr Infect Dis J 33, e158-e161.